Biopharma Spectrum To Be Driven By Automation In Next Decade

As per a market report, all across 2023 to 2033, automation in the biopharmaceutical sector will be driven by artificial intelligence and robotics solutions.

Significant Cost Savings A Possibility With Biosimilars

With four-fold increase over last 5 years, biosimilar savings are expected to cross $180 billion in next 5 years, but interchangeability should be considered.

Microbial Fermentation Tech Market To Cross $56b In 2023

Global microbial fermentation technology segment is expected to see a surge in 2023 thanks to the growing influx of Artificial Intelligence in this landscape.

Randomized Trials Backed By FDA For Speedy Drug Approvals

FDA is planning to go ahead with randomized controlled trials when it comes to the approval of oncology drugs thereby to fast-track breakthrough medications.

FDA New Drug Office Underlines Research Projects For Growth

The program looks out to emphasize on specific questions that will go out to impact how CDER and FDA would go on to make effective drug approval decisions.

Stem Cell Plan To Vision Recovery – Singapore, Sweden Study

Collaborators from Singapore and Sweden have taken the initial step for restoration of vision for eye diseases that are characterized by photoreceptor loss.

Human Lungs Created To Test Drugs By Australian Scientists

An advanced human lung model has been created by Australian scientists to accelerate evaluation of novel drugs and reduce the dependency on Animal testing.